The combination therapy of salinomycin and gefitinib using poly(d,l-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles for targeting both lung cancer stem cells and cancer cells

References

• SiegelRLMillerKDJemalACancer statisticsCA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• HirschFRSudaKWiensJBunnPAJrNew and emerging targeted treatments in advanced non-small-cell lung cancerLancet20163881004810121012427598681
   PubMed Web of Science ®Google Scholar
• KarachaliouNSosaAEBarronFBGonzalez CaoMSantarpiaMRosellRPharmacological management of relapsed/refractory NSCLC with chemical drugsExpert Opin Pharmacother201718329530428103738
   PubMed Web of Science ®Google Scholar
• PopperHHProgression and metastasis of lung cancerCancer Metastasis Rev2016351759127018053
   PubMed Web of Science ®Google Scholar
• MacDonaghLGraySGBreenELung cancer stem cells: the root of resistanceCancer Lett2016372214715626797015
   PubMed Web of Science ®Google Scholar
• LeonGMacDonaghLFinnSPCuffeSBarrMPCancer stem cells in drug resistant lung cancer: targeting cell surface markers and signaling pathwaysPharmacol Ther2016158719026706243
   PubMed Web of Science ®Google Scholar
• ZhouBBZhangHDamelinMGelesKGGrindleyJCDirksPBTumour-initiating cells: challenges and opportunities for anticancer drug discoveryNat Rev Drug Discov200981080682319794444
   PubMed Web of Science ®Google Scholar
• GaoJLiWGuoYFengSSNanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cellsNanomedicine (Lond)201611243261328227854161
   PubMedGoogle Scholar
• XieFXuWYinCZhangGZhongYGaoJNanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive systemWorld J Gastrointest Oncol201681073574427795813
   PubMed Web of Science ®Google Scholar
• LundinADriscollBLung cancer stem cells: progress and prospectsCancer Lett20133381899322906416
   PubMed Web of Science ®Google Scholar
• BertoliniGRozLPeregoPHighly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatmentProc Natl Acad Sci U S A200910638162811628619805294
   PubMed Web of Science ®Google Scholar
• EramoALottiFSetteGIdentification and expansion of the tumorigenic lung cancer stem cell populationCell Death Differ200815350451418049477
   PubMed Web of Science ®Google Scholar
• NaujokatCSteinhartRSalinomycin as a drug for targeting human cancer stem cellsJ Biomed Biotechnol2012201295065823251084
   PubMedGoogle Scholar
• GuptaPBOnderTTJiangGIdentification of selective inhibitors of cancer stem cells by high-throughput screeningCell2009138464565919682730
   PubMed Web of Science ®Google Scholar
• MaoXLiuJGongZiRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cellsNanomedicine (Lond)201510172677269526355733
   PubMedGoogle Scholar
• YueWHamaïATonelliGInhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenanceAutophagy20139571472923519090
   PubMed Web of Science ®Google Scholar
• LarzabalLEl-NikhelyNRedradoMSeegerWSavaiRCalvoADifferential effects of drugs targeting cancer stem cell (CSC) and non-CSC populations on lung primary tumors and metastasisPLoS One2013811e7979824278179
   PubMed Web of Science ®Google Scholar
• WangYEffects of salinomycin on cancer stem cell in human lung adenocarcinoma A549 cellsMed Chem20117210611121222617
   PubMed Web of Science ®Google Scholar
• GaoJFengSSGuoYNanomedicine for treatment of cancer stem cellsNanomedicine (Lond)20149218118424552558
   PubMedGoogle Scholar
• OtsukaHNagasakiYKataokaKPEGylated nanoparticles for biological and pharmaceutical applicationsAdv Drug Deliv Rev200355340341912628324
   PubMed Web of Science ®Google Scholar
• GuptaPBFillmoreCMJiangGStochastic state transitions give rise to phenotypic equilibrium in populations of cancer cellsCell2011146463364421854987
   PubMed Web of Science ®Google Scholar
• IliopoulosDHirschHAWangGStruhlKInducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretionProc Natl Acad Sci U S A201110841397140221220315
   PubMed Web of Science ®Google Scholar
• ChafferCLBrueckmannIScheelCNormal and neoplastic nonstem cells can spontaneously convert to a stem-like stateProc Natl Acad Sci U S A2011108197950795521498687
   PubMed Web of Science ®Google Scholar
• ChenDXieFSunDYinCGaoJZhongYNanomedicine-mediated combination drug therapy in tumorOpen Pharm Sci J20174110
   Google Scholar
• KeXYLin NgVWGaoSJTongYWHedrickJLYangYYCo-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cellsBiomaterials20143531096110824183698
   PubMed Web of Science ®Google Scholar
• PaezJGJännePALeeJCEGFR mutations in lung cancer: correlation with clinical response to gefitinib therapyScience200430456761497150015118125
   PubMed Web of Science ®Google Scholar
• PaoWMillerVZakowskiMEGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProc Natl Acad Sci U S A200410136133061331115329413
   PubMed Web of Science ®Google Scholar
• GongZChenDXieFCo-delivery of salinomycin and doxorubicin using nanoliposomes for targeting both liver cancer cells and cancer stem cellsNanomedicine (Lond)201611192565257927647449
   PubMed Web of Science ®Google Scholar
• XieFZhangSLiuJCodelivery of salinomycin and chloroquine by liposomes enables synergistic antitumor activity in vitroNanomedicine (Lond)201611141831184627391366
   PubMed Web of Science ®Google Scholar
• SongHSuXYangKCD20 antibody-conjugated immunoliposomes for targeted chemotherapy of melanoma cancer initiating cellsJ Biomed Nanotech2015111119271946
   PubMed Web of Science ®Google Scholar
• HuangWTLarssonMLeeYCLiuDMChiouGYDual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cellsEur J Pharm Biopharm201610916517327793756
   PubMed Web of Science ®Google Scholar
• ZhangJZhangCHuLAbnormal expression of mir-21 and mir-95 in cancer stem-like cells is associated with radioresistance of lung cancerCancer Invest201533516517125831148
   PubMed Web of Science ®Google Scholar
• NystromAMFadeelBSafety assessment of nanomaterials: implications for nanomedicineJ Control Release2012161240340822306428
   PubMed Web of Science ®Google Scholar
• SullivanJPSpinolaMDodgeMAldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signalingCancer Res201070239937994821118965
   PubMed Web of Science ®Google Scholar
• ShaoCSullivanJPGirardLEssential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathwayClin Cancer Res201420154154416624907115
   PubMed Web of Science ®Google Scholar